These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9186870)

  • 1. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
    Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin.
    Lan HY; Zarama M; Nikolic-Paterson DJ; Kerr PG; Atkins RC
    J Am Soc Nephrol; 1993 May; 3(11):1765-74. PubMed ID: 8329671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
    Lan HY; Bacher M; Yang N; Mu W; Nikolic-Paterson DJ; Metz C; Meinhardt A; Bucala R; Atkins RC
    J Exp Med; 1997 Apr; 185(8):1455-65. PubMed ID: 9126926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
    Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
    Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist.
    Lan HY; Nikolic-Paterson DJ; Zarama M; Vannice JL; Atkins RC
    Kidney Int; 1993 Feb; 43(2):479-85. PubMed ID: 8441245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
    Tang WW; Feng L; Vannice JL; Wilson CB
    J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation.
    Huang XR; Holdsworth SR; Tipping PG
    Kidney Int; 1994 Jul; 46(1):69-78. PubMed ID: 7523756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice.
    Kitching AR; Tipping PG; Huang XR; Mutch DA; Holdsworth SR
    Kidney Int; 1997 Jul; 52(1):52-9. PubMed ID: 9211346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
    Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC
    Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
    Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
    Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
    Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
    Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
    Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
    Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
    Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
    Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat.
    Lan HY; Nikolic-Paterson DJ; Mu W; Vannice JL; Atkins RC
    Kidney Int; 1995 May; 47(5):1303-9. PubMed ID: 7637259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.
    Yang N; Nikolic-Paterson DJ; Ng YY; Mu W; Metz C; Bacher M; Meinhardt A; Bucala R; Atkins RC; Lan HY
    Mol Med; 1998 Jun; 4(6):413-24. PubMed ID: 10780884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6.
    Karkar AM; Smith J; Tam FW; Pusey CD; Rees AJ
    Kidney Int; 1997 Nov; 52(5):1313-20. PubMed ID: 9350654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
    Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
    J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney.
    Tesch GH; Yang N; Yu H; Lan HY; Foti R; Chadban SJ; Atkins RC; Nikolic-Paterson DJ
    Nephrol Dial Transplant; 1997 Jun; 12(6):1109-15. PubMed ID: 9198037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.